Windward Bio Group AG Company Profile
NASDAQ: WWBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Windward Bio Group at a glance
Windward Bio Group AG (NASDAQ: WWB) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Basel, Switzerland. Windward Bio Group is led by Dr. Luca Santarelli M.D. and employs about 33 people. The company's shares have traded publicly since 2026.
At a market capitalization of $1.43 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002145089, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Windward Bio Group do?
Windward Bio Group AG operates as a clinical stage biotechnology company that develops ultra-long-acting antibody medicines for patients with respiratory and dermatologic diseases. Its drug candidates WIN378, an ultra-long-acting and novel fully human monoclonal antibody, which has completed Phase I clinical study that inhibits thymic stromal lymphopoietin (TSLP); and WIN027, an ultra-long-acting bispecific antibody that is in Phase I clinical study simultaneously targets TSLP and interleukin-13 (IL-13) and two clinically validated drivers of inflammatory disease. The company has collaboration agreements with Sichuan Kelun-Biotech BioPharmaceutical Co., Ltd, Harbour BioMed (Shanghai) Co., Ltd, and Qyuns Therapeutics Co., Ltd. Windward Bio Group AG was incorporated in 2024 and is based in Basel, Switzerland.
Business description based on the company's public filings.
Company information
- Legal name
- Windward Bio Group AG
- Ticker
- NASDAQ: WWB
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Dr. Luca Santarelli M.D.
- Employees
- 33
- Headquarters
- Aeschenplatz 6, Basel, Switzerland
- Phone
- 41 61 551 75 75
- Website
- windwardbio.com
- IPO year
- 2026
- Market cap
- $1.43B
- SEC CIK
- 0002145089
Companies similar to Windward Bio Group
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MESOMesoblast Limited ADR | 10.89 | -2.59% | $1.41B | vs WWB |
| ALVOAlvotech | 4.12 | -3.96% | $1.47B | vs WWB |
| IMCRImmunocore Holdings plc ADR | 26.41 | -0.83% | $1.36B | vs WWB |
| RXRXRecursion Pharmaceuticals Inc. Class A | 2.45 | -9.93% | $1.53B | vs WWB |
| VIRVir Biotechnology Inc. | 8.39 | -5.41% | $1.56B | vs WWB |
| NVAXNovavax Inc. | 7.47 | -3.24% | $1.23B | vs WWB |
| TSHATaysha Gene Therapies Inc. | 3.72 | -1.33% | $1.21B | vs WWB |
| VORVor Biopharma Inc. | 19.19 | +3.62% | $1.18B | vs WWB |